PMID- 24379378 OWN - NLM STAT- MEDLINE DCOM- 20140506 LR - 20211021 IS - 1091-6490 (Electronic) IS - 0027-8424 (Print) IS - 0027-8424 (Linking) VI - 111 IP - 4 DP - 2014 Jan 28 TI - In vitro selection with artificial expanded genetic information systems. PG - 1449-54 LID - 10.1073/pnas.1311778111 [doi] AB - Artificially expanded genetic information systems (AEGISs) are unnatural forms of DNA that increase the number of independently replicating nucleotide building blocks. To do this, AEGIS pairs are joined by different arrangements of hydrogen bond donor and acceptor groups, all while retaining their Watson-Crick geometries. We report here a unique case where AEGIS DNA has been used to execute a systematic evolution of ligands by exponential enrichment (SELEX) experiment. This AEGIS-SELEX was designed to create AEGIS oligonucleotides that bind to a line of breast cancer cells. AEGIS-SELEX delivered an AEGIS aptamer (ZAP-2012) built from six different kinds of nucleotides (the standard G, A, C, and T, and the AEGIS nonstandard P and Z nucleotides, the last having a nitro functionality not found in standard DNA). ZAP-2012 has a dissociation constant of 30 nM against these cells. The affinity is diminished or lost when Z or P (or both) is replaced by standard nucleotides and compares well with affinities of standard GACT aptamers selected against cell lines using standard SELEX. The success of AEGIS-SELEX relies on various innovations, including (i) the ability to synthesize GACTZP libraries, (ii) polymerases that PCR amplify GACTZP DNA with little loss of the AEGIS nonstandard nucleotides, and (iii) technologies to deep sequence GACTZP DNA survivors. These results take the next step toward expanding the power and utility of SELEX and offer an AEGIS-SELEX that could possibly generate receptors, ligands, and catalysts having sequence diversities nearer to that displayed by proteins. FAU - Sefah, Kwame AU - Sefah K AD - Department of Chemistry, University of Florida, Gainesville, FL 32611. FAU - Yang, Zunyi AU - Yang Z FAU - Bradley, Kevin M AU - Bradley KM FAU - Hoshika, Shuichi AU - Hoshika S FAU - Jimenez, Elizabeth AU - Jimenez E FAU - Zhang, Liqin AU - Zhang L FAU - Zhu, Guizhi AU - Zhu G FAU - Shanker, Savita AU - Shanker S FAU - Yu, Fahong AU - Yu F FAU - Turek, Diane AU - Turek D FAU - Tan, Weihong AU - Tan W FAU - Benner, Steven A AU - Benner SA LA - eng GR - R01 GM079359/GM/NIGMS NIH HHS/United States GR - R21 CA122648/CA/NCI NIH HHS/United States GR - GM079359/GM/NIGMS NIH HHS/United States GR - R01 CA133086/CA/NCI NIH HHS/United States GR - R21CA122648/CA/NCI NIH HHS/United States GR - CA133086/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20131230 PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (DNA Primers) SB - IM MH - Base Sequence MH - DNA Primers MH - *Information Systems MH - Polymerase Chain Reaction MH - SELEX Aptamer Technique MH - *Selection, Genetic PMC - PMC3910645 OTO - NOTNLM OT - cancer cell SELEX OT - next generation sequencing OT - nucleic acids OT - synthetic biology COIS- S.A.B., Z.Y., and the Foundation for Applied Molecular Evolution hold patents and patent applications for various of the AEGIS compounds and in vitro selection with expanded genetic alphabets. EDAT- 2014/01/01 06:00 MHDA- 2014/05/07 06:00 PMCR- 2014/07/28 CRDT- 2014/01/01 06:00 PHST- 2014/01/01 06:00 [entrez] PHST- 2014/01/01 06:00 [pubmed] PHST- 2014/05/07 06:00 [medline] PHST- 2014/07/28 00:00 [pmc-release] AID - 1311778111 [pii] AID - 201311778 [pii] AID - 10.1073/pnas.1311778111 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 2014 Jan 28;111(4):1449-54. doi: 10.1073/pnas.1311778111. Epub 2013 Dec 30.